期刊文献+

IFN-γ-IL-32-IL-1β反馈环对判断慢性阻塞性肺疾病急性加重期病情轻重及预后的意义 被引量:10

下载PDF
导出
摘要 目的探讨IFN-γ-IL-32-IL-1β反馈环对判断慢性阻塞性肺疾病急性加重期(AECOPD)患者病情轻重及预后的意义。方法应用酶联免疫吸附法(ELISA)检测50例AECOPD存活组3、0例AECOPD死亡患者(死亡组)在治疗前后血清干扰素γ(IFN-γ)、白细胞介素1β(IL-1β)和白细胞介素32(IL-32)的浓度。结果 (1)存活组治疗后IFN-γI、L-1β和IL-32的浓度较治疗前均显著下降(P<0.01);死亡组终末期IL-1β的浓度较治疗前显著升高(P<0.05),IFN-γ和IL-32的浓度较治疗前均升高,但差异无统计学意义(P>0.05)。(2)IL-1β的浓度与AECOPD患者的死亡呈正相关(P<0.05)I,FN-γI、L-32浓度与AECOPD患者的死亡无相关性(P>0.05)。结论 IFN-γ-IL-32-IL-1β反馈环的偏移可能与AECOPD患者的病情轻重有关I,L-1β的浓度升高可作为AECOPD患者的死亡危险因素之一。
作者 范春红 李明
出处 《广东医学》 CAS CSCD 北大核心 2012年第4期484-486,共3页 Guangdong Medical Journal
基金 广东省佛山市卫生局医学科研立项项目(编号:2010406)
  • 相关文献

参考文献7

  • 1AARON S D,ANGEL J B.LUNAU M.Granulocyte IFN lammatory markers and airway IFN ection during acute exacerbation of chronic obstructive puonary disease[J].Am J Respir Crit Care Med,2001,163(2):349-355.
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3KIM S H,HAN S Y,AZAM T A,et al.Intedeukin-32:a eytokine and indueer of TNF alpha[J].Immunity,2005,22(1):131-142.
  • 4MCGUINNESS P H,PAINTER D,DAVIES S,et al.Increases in intrahepatic CD68 positive cells,MAC387 positive cells,and pro IFN lammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection[J].Gut,2000,46(2):260-269.
  • 5PANG G,ORTEGA M,ZIGHANG R,et al.Autocrine modulation of IL-8 production by sputum neutrophila in chronic bronchial sepsis[J].Am J Respir Crit Care Med,1997,155(2):726-731.
  • 6RUSSELL R E,CULPITT S V,DEMATOS C,et al.Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive puonary disease[J].Am J Respir Cell Mol Biol,2002,26(5):602-609.
  • 7KOCHETKOVA E A,VOLKOVA M V,SUROVENKO T N.Cytokine status in patients with chronic obstructive puonary diseases and its relationship with bone tissue functional state[J].Ter Arkh,2004,76(3):23-27.

二级参考文献7

共引文献8232

同被引文献85

  • 1何智辉,陈平.慢性阻塞性肺疾病患者体内白介素-6和C反应蛋白质量浓度的变化及意义[J].中国实用内科杂志,2006,26(7):989-991. 被引量:50
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8233
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1794
  • 4卫生部统计信息中心.2006年中国卫生事业发展情况统计公报[EB/OL].http://www.moh.gov.cn/newshtml/18903.htm,2007 -05 -09/2007 -06 -02.
  • 5Papaetis GS, Anastasakou E, Tselou T, et al. Serological evidence of Mycoplasma pneumoniae infection in patients with acute exacerbation of COPD: analysis of 1 00 hospitalizations[J]. Adv Med Sci,2010,55(2) :235-241.
  • 6CALABRESE F,BARALDO S,BAZZAN E,et al.IL-32,a novelproinflammatory cytokine in chronic obstructive pulmonary disease[J].AM J Respir Crit Care Med,2008,178(9):894-901.
  • 7KIM SH,HAN SY,AZAM TA,et al.Interleukin-32:acytokine and inducer of TNF-a[J].Immunity,2005,22 (1):131-142.
  • 8NETEA MG,AZAM T,LEWIS EC,et al.Mycobacterium tuberculosisinduces interleukin-32 production through a Caspaseq/ IL-18 /interferon-γdependent mechanism[J].PloS Med,2006,3:277.
  • 9KUNDU M,BASU J.IL-32:An emerging player in the immune responsenetwork against tuberculosis[J].PloS Med,2006,3:274.
  • 10HIROFUMI S,KEISHI F,YUMI Y,et al.Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases[J].Arthritis Res Ther,2006,8:1-13.

引证文献10

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部